Facilitator portal
Full releaseInbox and dossier review
Dossiers arrive as read-only documents with the unresolved forks already isolated. Countersigning extends a provisional answer's validity.
Classical churna, therapeutic claim, one unresolved slot
esc-3301 · received 2026-08-30
Determination
Appears as-is in a First Schedule text · Therapeutic claim elected · Classical ASU medicine
Citation set
- 1. Patents Act 1970, Section 3(p)Verified span
- 2. Patents Act 1970, Section 3(d)Verified span
- 3. Biological Diversity Act 2002, Section 6Verified span
- 4. Bhaishajya Ratnavali, Jvara Chikitsa, verse 42Curated table
Agenda for you
- 1. Is this a standardised extract with a defined marker compound? If yes, Section 3(d) enters and the patentability answer changes.
- 2. Confirm NBA prior-approval status before any filing is prepared.
- 3. WIPO GRATK Article 3 has no domestic implementing provision. Confirm whether the client intends to file abroad.
Countersigning records your name and registration number in the hash-chained audit log and extends the provisional answer past its expiry date.